A detailed history of Caxton Associates LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 17,600 shares of GILD stock, worth $1.63 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
17,600
Holding current value
$1.63 Million
% of portfolio
0.06%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$66.59 - $83.99 $1.17 Million - $1.48 Million
17,600 New
17,600 $1.48 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $254,057 - $277,182
3,436 Added 39.47%
12,141 $909,000
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $661,667 - $754,723
8,705 New
8,705 $670,000
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $47.9 Million - $68.8 Million
769,230 New
769,230 $66 Million
Q3 2020

Nov 16, 2020

SELL
$62.1 - $78.08 $387,938 - $487,765
-6,247 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $451,907 - $524,748
6,247 New
6,247 $481,000
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $199,159 - $223,334
-3,219 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $201,284 - $225,490
3,219 New
3,219 $209,000
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $856,545 - $999,127
-13,202 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$72.84 - $88.8 $961,633 - $1.17 Million
13,202 New
13,202 $995,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.